Friday, March 02, 2007 1:31:47 AM
Wednesday February 21, 9:59 am ET
MATAWAN, N.J.--(BUSINESS WIRE)--PacificHealth Laboratories, Inc. (OTCBB: PHLI - News), a nutrition technology company, said that at an Investors Conference held in London yesterday, Todd Stitzer, CEO of Cadbury Schweppes, officially announced the national multi-channel launch of ACCELERADE RTD. Product will be shipped in the second quarter. ACCELERADE is part of a major innovation drive by Cadbury Schweppes. Because of its proven benefits, Stitzer described ACCELERADE as the "holy grail" for serious exercisers. To hear the Feb 20 presentation, go to www.cadburyschweppes.com/EN/InvestorCentre/Presentations/.
ACCELERADE was part of an asset purchase agreement between PacificHealth Laboratories and Motts, LLP, a division of Cadbury Schweppes Americas Beverage ("CSAB"). Under the terms of the agreement PHLI received an upfront payment of $4 million, a royalty payment for a finite period of time and a royalty-free license to continue selling ACCELERADE and ENDUROX R4® in powder and gel forms.
Dr. Robert Portman, Chairman and CEO of PHLI said, "We have been working closely with CSAB for the past year in coordinating our efforts. We have completely revamped all of the ACCELERADE powder and ACCEL GEL® packaging so that it is consistent with the new RTD label. Additionally, we have instituted an aggressive program involving the placement of permanent point of purchase displays in leading sports specialty stores. I anticipate that the marketing and advertising efforts by Cadbury in supporting the ACCELERADE brand will have a significant benefit to powder and gel sales. We are implementing a number of programs to fully take advantage of this opportunity."
ACCELERADE, developed by PacificHealth Laboratories, is the first sports drink that contains a patented 4:1 ratio of carbohydrate to protein. Fifteen studies have now been conducted documenting the benefits of a 4:1 ratio in terms of improved endurance, enhanced rehydration, faster muscle recovery and less post-exercise muscle damage. For more information visit www.accelerade.com.
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM